DocGo Inc.
DCGO· Nasdaq
Filed Aug 8, 2023 · 10-Q · 39 days after period end · 0001628280-23-028244
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Revenue | $125.49M | $109.52M | $62.19M |
| Net Income | $1.34M | $11.76M | $102.01K |
| EPS Diluted | -$0.02 | $0.11 | -$18.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DocGo Inc. · CIK 1822359 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 8, 2023 · 39 d after period end